Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...
A Tennessee bill would let optometrists perform eye surgery. An ophthalmologist warns this threatens patient safety.
CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...
If you have wet age-related macular degeneration (wet AMD) or another disease of the retina, your doctor may recommend treatment with an anti-VEGF drug. VEGF, or vascular endothelial growth factor, is ...
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...
Masking during intravitreal anti-VEGF injections was associated with a similar incidence of endophthalmitis compared to not masking, in a large retrospective study. After adjusting for the use of ...
"As health care systems continue to adapt to the challenges posed by the COVID-19 pandemic, our study highlights the need for targeted interventions to address regional disparities and ensure that ...